Vulvar und vaginales Plattenepithelkarzinom
Deterministische Ansicht der Quelle YAML Entität. Klinische Autorität bleibt mit den zitierten Quell-IDs und Rezensenten Sign-off Zustand.
| ID | DIS-VULVAR-VAGINAL-SCC |
|---|---|
| Art | Erkrankung |
| Aliase | HPV-assoziierte Vulvar-SCCLichen-Sklerosus-abgeleitete SCCVIN-abgeleitete SCCVaginal SCCVulvar SCCПлоскоклітинна карцинома вульви та піхви |
| Status | reviewed 2026-05-18 | pending_clinical_signoff |
| Erkrankungen | None declared |
| Quellen | SRC-IARC-MONO-100B-2012 SRC-NCCN-CERVICAL-2025 |
Informational support. All recommendations must be verified by a qualified oncologist. Engineering checks are not clinical validation or treatment approval.
| icd_o_3_morphology | 8070/3 |
|---|---|
| icd_o_3_topography | ["C51", "C52"] |
| icd_10 | C51, C52 |
| who_classification | WHO Weibliche Genitaltumore 5 ed (2020): Vulvar SCC (HPV-assoziiert + HPV-unabhängig) und Vaginal SCC |
Anmerkungen
Two biological subgroups managed similarly anatomically but with distinct prevention implications: HPV-driven (vaccination prevents precursor lesions; screening with vulvar exam + biopsy of any persistent lesion) vs HPV-independent (lichen sclerosus surveillance is the dominant prevention modality; topical clobetasol may reduce malignant transformation in select cohorts). Treatment: early-stage — wide local excision ± inguinal sentinel node biopsy (GROINSS-V paradigm replacing routine complete inguinofemoral lymphadenectomy); locally advanced — definitive chemoradiation (cisplatin + RT); metastatic — pembrolizumab if PD-L1+ (KEYNOTE-158 cohort). Vaginal SCC managed similarly with RT-based approaches (anatomic constraints limit surgical options).
Verwendet von
Algorithmen
ALGO-VULVAR-VAGINAL-SCC-1L- ALGO-VULVAR-VAGINAL-SCC-1L
Erkrankung
DIS-PENILE-SCC- Penis Plattenepithelkarzinom
Anwendungsgebiet
IND-IATROGENIC-DES-EXPOSURE-PREVENTION-OBSERVATION- IND-IATROGENIC-DES-EXPOSURE-PREVENTION-OBSERVATIONIND-IATROGENIC-DES-EXPOSURE-PREVENTION-SURVEILLANCE- IND-IATROGENIC-DES-EXPOSURE-PREVENTION-SURVEILLANCEIND-VULVAR-VAGINAL-SCC-1L-WLE-SLNB- IND-VULVAR-VAGINAL-SCC-1L-WLE-SLNBIND-VULVAR-VAGINAL-SCC-LA-1L-CISPLATIN-RT- IND-VULVAR-VAGINAL-SCC-LA-1L-CISPLATIN-RTIND-VULVAR-VAGINAL-SCC-METASTATIC-1L-PEMBRO- IND-VULVAR-VAGINAL-SCC-METASTATIC-1L-PEMBRO
Warnhinweis
RF-IATROGENIC-DES-EXPOSURE-PREVENTION- In-utero exposure to diethylstilbestrol (DES), a synthetic non- steroidal estrogen prescr...RF-REPRODUCTIVE-DES-IN-UTERO-EXPOSURE-PREVENTION- In-utero exposure to diethylstilbestrol (DES) — synthetic non-steroidal estrogen prescrib...RF-VULVAR-VAGINAL-SCC-PDL1-CPS-1-PLUS- Vorher behandelte, wiederkehrende oder metastasierende Vulvar oder vaginales Plattenepithelkarzinom mit...
Quellen
SRC-GROINSS-V-VANDERZEE-2008- Sentinelknoten-Desektion ist sicher in der Behandlung von Frühstadium Vulvar Krebs (GROINSS-V...SRC-KEYNOTE-158-VULVAR-SHAPIRA-FROMMER-2022- Wirksamkeit und Sicherheit von Pembrolizumab bei Patienten mit zuvor behandelter fortgeschrittener Vulvar...